| |
|
| |
|
|
By: Blanco |
S.B. No. 2212 |
|
|
(In the Senate - Filed March 9, 2023; March 22, 2023, read |
|
|
first time and referred to Committee on Health & Human Services; |
|
|
April 25, 2023, reported adversely, with favorable Committee |
|
|
Substitute by the following vote: Yeas 6, Nays 0; April 25, 2023, |
|
|
sent to printer.) |
| Click here to see the committee vote |
| |
|
|
COMMITTEE SUBSTITUTE FOR S.B. No. 2212 |
By: Kolkhorst |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
| |
|
|
relating to the disclosure by a pharmacy to a patient of certain |
|
|
price information for a drug or biological product. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Section 562.003, Occupations Code, is amended to |
|
|
read as follows: |
|
|
Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A |
|
|
pharmacy shall disclose the lowest cost cash price at that pharmacy |
|
|
for the drug or biological product prescribed to the patient. |
|
|
(b) If the price of a drug or biological product to a patient |
|
|
is lower than the amount of the patient's copayment under the |
|
|
patient's prescription drug insurance plan, the pharmacist shall |
|
|
offer the patient the option of paying for the drug or biological |
|
|
product at the lower price instead of paying the amount of the |
|
|
copayment. |
|
|
SECTION 2. This Act takes effect September 1, 2023. |
|
|
|
|
|
* * * * * |